首页> 外文期刊>Lab on a chip >Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP)
【24h】

Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP)

机译:使用多孔孔流分离(MOFF)和介电电泳(DEP)从血液样本中连续分离乳腺癌细胞

获取原文
获取原文并翻译 | 示例
       

摘要

Circulating tumor cells (CTCs) are highly correlated with the invasive behavior of cancer, so their isolations and quantifications are important for biomedical applications such as cancer prognosis and measuring the responses to drug treatments. In this paper, we present the development of a microfiuidic device for the separation of CTCs from blood cells based on the physical properties of cells. For use as a CTC model, we successfully separated human breast cancer cells (MCF-7) from a spiked blood cell sample by combining multi-orifice flow fractionation (MOFF) and dielectrophoretic (DEP) cell separation technique. Hydrodynamic separation takes advantage of the massive and high-throughput filtration of blood cells as it can accommodate a very high flow rate. DEP separation plays a role in precise post-processing to enhance the efficiency of the separation. The serial combination of these two different sorting techniques enabled high-speed continuous flow-through separation without labeling. We observed up to a 162-fold increase in MCF-7 cells at a 126 μL min~(-1) flow rate. Red and white blood cells were efficiently removed with separation efficiencies of 99.24% and 94.23% respectively. Therefore, we suggest that our system could be used for separation and detection of CTCs from blood cells for biomedical applications.
机译:循环肿瘤细胞(CTC)与癌症的侵袭行为高度相关,因此它们的分离和定量对于生物医学应用(例如癌症预后和衡量对药物治疗的反应)至关重要。在本文中,我们介绍了一种基于细胞物理特性的微流体装置,用于从血细胞中分离四氯化碳。作为CTC模型,我们通过结合多孔流分离(MOFF)和介电电泳(DEP)细胞分离技术,成功地从加标血细胞样品中分离了人乳腺癌细胞(MCF-7)。流体动力分离利用了血细胞的大规模高通量过滤优势,因为它可以容纳非常高的流速。 DEP分离在精确的后处理中发挥作用,以提高分离效率。这两种不同的分选技术的串行组合使无需标签即可进行高速连续流通分离。我们观察到在126μLmin〜(-1)流速下,MCF-7细胞增加了162倍。有效去除红细胞和白细胞,分离效率分别为99.24%和94.23%。因此,我们建议我们的系统可用于从血细胞中分离和检测CTC,用于生物医学应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号